A well-coordinated value communication program goes beyond payers and physicians to include other access journey stakeholders, such as medical communities and provider organizations, as well as patients and their influencers. 

Deep understanding of your audience and their objectives, needs and evidence requirements will help you formulate and communicate a more compelling value story and messages that impact decision-making.

We’ll help you identify critical evidence needs to enable the communication of a drug’s value to stakeholders, and confirm realistic price and market access expectations—and then apply these insights to improve your clinical development program.

Work with us to develop a value strategy that aligns with your pricing strategy, includes supporting health economic models and quality of life assessments, and is relevant to all decision makers to help ensure your commercial success. 

Life sciences organizations spend billions engaging with payers and providers to ensure access to their products. Optimizing access requires comprehensive customer insights, analytical sophistication and the agility to adapt to the evolving healthcare landscape. Watch the video to learn how ZS applies an analytechs mindset, which combines analytics and technology to help pharma companies build future-forward approaches to market access.